ABOUT US

Corporate Governance

Overview

Biosimilar Pharmaceuticals

Sales and Marketing

Manufacturing

Board of Directors

Corporate Governance
Company Trading Policy

 

 

SciGen Ltd and the Board are committed to achieving and demonstrating the highest standards of corporate governance. The company's corporate governance framework is largely consistent with the Best Practice recommendations released by the Australian Stock Exchange Corporate Governance Council when taking into account the size and scope of the company. SciGen and its controlled entities are collectively referred to as ‘the Group' in this statement. A summary of the compliance status of the Group under the broad principle headings as defined in the guidelines is shown below

 
  Principle 1
  Principle 2
  Principle 3
  Principle 4
  Principle 5
  Principle 6
  Principle 7
  Principle 8
  Principle 9
  Principle 10